To the genesis of Burkitt lymphoma: Regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes
Authors:
- Noemi NagyNNNoemi Nagy
- George KleinGKGeorge Klein
- Eva KleinEKEva Klein
- 31 December 2009
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 19 (6) , 407-410
Abstract
No abstract availableKeywords
Funding Information
- Swedish Cancer Society
This publication has 32 references indexed in Scilit:
- The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative diseaseProceedings of the National Academy of Sciences, 2009
- Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene SapBlood, 2005
- SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cellsBlood, 2005
- Epstein–Barr virus: 40 years onNature Reviews Cancer, 2004
- p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53Oncogene, 2001
- Recurrent B‐cell non‐Hodgkin's lymphoma in two brothers with X‐linked lymphoproliferative disease without evidence for Epstein–Barr virus infectionBritish Journal of Haematology, 2000
- Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cellsOncogene, 1998
- Correction of Duncan's syndrome by allogeneic bone marrow transplantationThe Lancet, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)The Lancet, 1975